Biocon announced that its subsidiary, Biocon Biologics has received the certificate of GMP compliance from EMA represented by the competent authority of Germany for its Biological Drug Substance (DS) facilities at 20th KM, Hosur Road, Bangaluru.
These facilities are used for the manufacture of drug substance of Pegfilgrastim and Recombinant Human Insulin and manufacturing related activities for Insulin Glargine and Insulin Aspart and were inspected by the regulatory agency between 20 -23 January 2020.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
